| 2025 | 2024 | 2023 | 2022 | 2021 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 1,8 M € | — | |||||
| Gross margin | 2,6 M € | +42.6% | 1,8 M € | +35.8% | 1,4 M € | +11.1% | 1,2 M € | +278.6% | -685,4 k € | |
| EBITDA | 459,9 k € | +28.3% | 358,6 k € | +44.0% | 249,0 k € | -72.4% | 903,2 k € | +224.2% | -727,4 k € | |
| Operating profit | 258,2 k € | +54.8% | 166,8 k € | +37.6% | 121,2 k € | -86.5% | 894,9 k € | +206.9% | -837,4 k € | |
| Profit/loss | 261,7 k € | +39.3% | 187,9 k € | +51.2% | 124,3 k € | -86.0% | 885,7 k € | +202.6% | -862,9 k € | |
| Equity | 3,0 M € | +9.7% | 2,7 M € | +7.5% | 2,5 M € | +5.2% | 2,4 M € | +59.1% | 1,5 M € | |
| Total assets | 3,6 M € | +9.2% | 3,3 M € | +1.6% | 3,2 M € | +10.3% | 2,9 M € | +91.0% | 1,5 M € | |
| Cash | 1,0 M € | +145.3% | 416,6 k € | +272.0% | 112,0 k € | +52.8% | 73,3 k € | -66.8% | 220,6 k € | |
| Debts | 497,2 k € | -11.3% | 560,5 k € | -19.8% | 699,3 k € | +33.7% | 523,2 k € | +2144.6% | 23,3 k € | |
| Staff | 17,8 | 13,5 | 10,6 | 2,7 | 0,8 | |||||
Private limited company · Leuven · incorporated on 02/11/2020 · 17,8 ETP
Private limited company profitable and well capitalised. Cash position rising (+145.3%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
K5 Therapeutics is a Private limited company incorporated in 2020. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Leuven. It employs on average 17,8 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette